<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cell and Gene Archives - Engineeringness</title>
	<atom:link href="https://engineeringness.com/tag/cell-and-gene/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>All Your Engineering Needs</description>
	<lastBuildDate>Thu, 05 Sep 2024 14:59:48 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>

<image>
	<url>https://engineeringness.com/wp-content/uploads/2025/04/cropped-1611530912453-32x32.jpeg</url>
	<title>Cell and Gene Archives - Engineeringness</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>UK Leads Global Cell and Gene Therapy Revolution with Groundbreaking Innovations</title>
		<link>https://engineeringness.com/uk-leads-global-cell-and-gene-therapy-revolution-with-groundbreaking-innovations/</link>
					<comments>https://engineeringness.com/uk-leads-global-cell-and-gene-therapy-revolution-with-groundbreaking-innovations/#respond</comments>
		
		<dc:creator><![CDATA[Hassan Ahmed]]></dc:creator>
		<pubDate>Thu, 05 Sep 2024 14:59:47 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Cell and Gene]]></category>
		<guid isPermaLink="false">https://engineeringness.com/?p=104153</guid>

					<description><![CDATA[<p>The UK’s cell and gene therapy sector is experiencing rapid growth, poised to be a global leader in advanced medical therapies. With large investments and clinical progress, the sector shows amazing potential in reshaping healthcare outcomes. A recent review by the Cell and Gene Therapy Catapult (CGT Catapult) emphasises the critical stage the industry is in, with proof of concept established through successful therapies such as CAR-T. &#8220;The UK can take the lead in harnessing these therapies to deliver life-changing benefits to patients and economic growth to the nation,” said Matthew Durdy, CEO of CGT Catapult. The sector has seen</p>
<p>The post <a href="https://engineeringness.com/uk-leads-global-cell-and-gene-therapy-revolution-with-groundbreaking-innovations/" data-wpel-link="internal">UK Leads Global Cell and Gene Therapy Revolution with Groundbreaking Innovations</a> appeared first on <a href="https://engineeringness.com" data-wpel-link="internal">Engineeringness</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>The UK’s cell and gene therapy sector is experiencing rapid growth, poised to be a global leader in advanced medical therapies. With large investments and clinical progress, the sector shows amazing potential in reshaping healthcare outcomes. A recent review by the <a href="https://ct.catapult.org.uk/" data-wpel-link="external" rel="nofollow external noopener noreferrer">Cell and Gene Therapy Catapult (CGT Catapult)</a> emphasises the critical stage the industry is in, with proof of concept established through successful therapies such as CAR-T. </p>



<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">
<p>&#8220;The UK can take the lead in harnessing these therapies to deliver life-changing benefits to patients and economic growth to the nation,” </p>
</blockquote>



<p>said Matthew Durdy, CEO of CGT Catapult.</p>



<p>The sector has seen a resurgence in confidence, with investment climbing from £0.77 billion in 2023 to £0.97 billion by March 2024. This financial boost is accompanied by the UK overtaking Europe in clinical trials, with 84 drugs in development. </p>



<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">
<p>&#8220;The UK&#8217;s leadership in cell and gene therapy is a testament to our unwavering dedication to patient-centric advancements that rewrite the boundaries of healthcare,&#8221; </p>
</blockquote>



<p>remarked Steve Bates, CEO of the <a href="https://www.bioindustry.org/" data-wpel-link="external" rel="nofollow external noopener noreferrer">UK BioIndustry Association (BIA)</a>.</p>



<p>Manufacturing capacity has also surged, with the country now hosting 29 advanced facilities, ensuring that the infrastructure supports the growing demand. The CGT Catapult reports a 14% increase in manufacturing space, driven by expansion in regions such as Scotland and northern England.</p>



<p>However, challenges remain, especially in scaling production and addressing the growing need for a skilled workforce. To tackle this, the CGT Catapult has started apprenticeships aimed at producing a skilled labour pool to support the burgeoning sector. </p>



<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">
<p>&#8220;We continue to see acceleration and expansion across the ATMP manufacturing ecosystem, with more therapies becoming closer to commercialization,&#8221; Durdy.</p>
</blockquote>



<p>Looking ahead, the UK’s position as a leader in cell and gene therapy is promising, but sustained growth will require continued investment and collaboration. These advancements are not only positioned to transform patient care but also to cement the UK as a hub for cutting-edge biotechnological innovation.</p>
<div class="saboxplugin-wrap" itemtype="http://schema.org/Person" itemscope itemprop="author"><div class="saboxplugin-tab"><div class="saboxplugin-gravatar"><img decoding="async" src="https://engineeringness.com/wp-content/uploads/2025/02/1649882991639.jpeg" width="100"  height="100" alt="" itemprop="image"></div><div class="saboxplugin-authorname"><a href="https://engineeringness.com/author/hassan-ahmed/" class="vcard author" rel="author" data-wpel-link="internal"><span class="fn">Hassan Ahmed</span></a></div><div class="saboxplugin-desc"><div itemprop="description"><p>Hassan graduated with a Master’s degree in Chemical Engineering from the University of Chester (UK). He currently works as a design engineering consultant for one of the largest engineering firms in the world along with being an associate member of the Institute of Chemical Engineers (IChemE).</p>
</div></div><div class="clearfix"></div><div class="saboxplugin-socials "><a title="Linkedin" target="_self" href="https://www.linkedin.com/in/hassan-ahmed-961781237/" rel="noopener nofollow external noreferrer" class="saboxplugin-icon-grey" data-wpel-link="external"><svg aria-hidden="true" class="sab-linkedin" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><path fill="currentColor" d="M100.3 480H7.4V180.9h92.9V480zM53.8 140.1C24.1 140.1 0 115.5 0 85.8 0 56.1 24.1 32 53.8 32c29.7 0 53.8 24.1 53.8 53.8 0 29.7-24.1 54.3-53.8 54.3zM448 480h-92.7V334.4c0-34.7-.7-79.2-48.3-79.2-48.3 0-55.7 37.7-55.7 76.7V480h-92.8V180.9h89.1v40.8h1.3c12.4-23.5 42.7-48.3 87.9-48.3 94 0 111.3 61.9 111.3 142.3V480z"></path></svg></span></a></div></div></div><p>The post <a href="https://engineeringness.com/uk-leads-global-cell-and-gene-therapy-revolution-with-groundbreaking-innovations/" data-wpel-link="internal">UK Leads Global Cell and Gene Therapy Revolution with Groundbreaking Innovations</a> appeared first on <a href="https://engineeringness.com" data-wpel-link="internal">Engineeringness</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://engineeringness.com/uk-leads-global-cell-and-gene-therapy-revolution-with-groundbreaking-innovations/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
